INVO Fertility (IVF) Return on Capital Employed Growth (3y) (2015 - 2025)
INVO Fertility (IVF) Return on Capital Employed Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 362.00 |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 | -4,721.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4,721.00 |
| Jun 30, 2025 | -6,746.00 |
| Mar 31, 2025 | -3,719.00 |
| Dec 31, 2024 | -8,503.00 |
| Sep 30, 2024 | 26,391.00 |
| Jun 30, 2024 | -13,428.00 |
| Mar 31, 2024 | -7,516.00 |
| Dec 31, 2023 | -2,737.00 |
| Sep 30, 2023 | 390,779.00 |
| Jun 30, 2023 | 3.52 Mn |
| Mar 31, 2023 | -55,457.00 |
| Dec 31, 2022 | -7,577.00 |
| Sep 30, 2022 | -1,294.00 |
| Jun 30, 2022 | -2,725.00 |
| Mar 31, 2022 | -14,290.00 |
| Dec 31, 2021 | -16,698.00 |
| Sep 30, 2021 | -10,979.00 |
| Jun 30, 2021 | -8,471.00 |
| Mar 31, 2021 | -3,406.00 |
| Dec 31, 2020 | -5,499.00 |